38 trillion bacteria inhabit the human body, most of them harmless or beneficial. A minority can cause severe infections, and the rise of drug-resistant strains has narrowed treatment options. Public health bodies flag antimicrobial resistance as a growing concern: World Health Organization underscores the need for new tools to complement existing medicines. One proposed approach is the systematic collection and characterization of bacteriophages—viruses that selectively infect bacteria—held in curated ‘libraries’ to be deployed against specific pathogens.
Phage collections serve multiple functions: they act as repositories of biologically diverse agents, allow rapid matching of phages to an infecting microbe, and support research on efficacy and safety. Because many phages target only particular bacterial species or strains, a well-characterized catalogue can speed therapeutic selection without broadly disrupting the host microbiome. Researchers emphasize standardized testing within these collections to confirm host range, stability and production feasibility before clinical use.
The appeal of phages lies in their specificity and their ability to evolve alongside bacterial targets. That specificity can reduce collateral damage caused by broad-spectrum antibiotics, but it also requires diagnostic precision and access to diverse phage stocks. Limitations include the potential for bacteria to develop resistance to phages, regulatory and manufacturing hurdles, and the need for quality control to ensure safety. Combining phage therapy with conventional antimicrobials or using phage cocktails are among the strategies under consideration to mitigate those risks.
Integrating phage libraries into clinical practice would shift elements of infectious-disease management toward more personalized responses, particularly in hospital settings where resistant infections are common. Success depends on coordinated surveillance, investment in infrastructure for phage isolation and characterization, and regulatory pathways that accommodate biologically active collections. As research progresses, curated phage repositories could become a complementary resource in the broader effort to preserve treatment options against stubborn bacterial threats.
